Carbamylation of proteins - mechanism, causes and consequences

被引:2
作者
Pieniazek, Anna [1 ]
Gwozdzinski, Krzysztof [2 ]
机构
[1] Uniwersytet Lodzki, Katedra Biofizyki Med, Wydzial Biol & Ochrony Srodowiska, Ul Pomorska 141-143, PL-90236 Lodz, Poland
[2] Uniwersytet Lodzki, Katedra Biofizyki Mol, Wydzial Biol & Ochrony Srodowiska, PL-90236 Lodz, Poland
来源
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ | 2016年 / 70卷
关键词
protein carbamylation; chronic renal failure; isocyanic acid; CHRONIC-RENAL-FAILURE; LOW-DENSITY-LIPOPROTEIN; MODIFICATION-DERIVED PRODUCTS; CHRONIC KIDNEY-DISEASE; IN-VITRO; PERITONEAL-DIALYSIS; OXIDATIVE STRESS; AMINO-ACIDS; ALBUMIN; CYANATE;
D O I
10.5604/17322693.1202189
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Carbamylation (carbamoylation) is a post-translational modification resulting from the nonenzymatic reaction between isocyanic acid and free functional groups of proteins, in particular with the free amino groups. This reaction alters structural and functional properties of proteins and results in faster aging of proteins. Urea present in the body can be transformed into cyanate and its more reactive form, isocyanic acid. High concentration of urea is associated with some diseases, especially with chronic renal failure and atherosclerosis. In human tissues, urea and cyanate are in equilibrium in aqueous solutions. Surprisingly, concentration of isocyanate in the body is much lower than it would appear from the kinetic parameters of urea decomposition. The low concentration of isocyanic acid results from its high reactivity and short half-life. In this review we describe the biochemical mechanism of carbamylation of proteins and free amino acids. We summarize the literature data for carbamylation of hemoglobin, lipoproteins, albumin, membrane proteins and erythropoietin in chronic renal failure. In summary, the carbamylation of proteins may have a negative impact on their biological activity and may contribute to the deterioration of patients with chronic renal failure.
引用
收藏
页码:514 / 521
页数:8
相关论文
共 50 条
[1]   Urea and atherosclerosis-evidence for a direct link involving apolipoprotein B protein modifications [J].
Albert, Christian ;
Mertens, Peter R. ;
Bartsch, Peter .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2011, 43 (03) :933-936
[2]  
[Anonymous], RES J CHEM SCI
[3]   Carbamylated Low-Density Lipoprotein: Nontraditional Risk Factor for Cardiovascular Events in Patients With Chronic Kidney Disease [J].
Apostolov, Eugene O. ;
Basnakian, Alexei G. ;
Ok, Ercan ;
Shah, Sudhir V. .
JOURNAL OF RENAL NUTRITION, 2012, 22 (01) :134-138
[4]   Chronic Uremia Stimulates LDL Carbamylation and Atherosclerosis [J].
Apostolov, Eugene O. ;
Ray, Debarti ;
Savenka, Alena V. ;
Shah, Sudhir V. ;
Basnakian, Alexei G. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (11) :1852-1857
[5]   Eosinophil peroxidase oxidation of thiocyanate - Characterization of major reaction products and a potential sulfhydryl-targeted cytotoxicity system [J].
Arlandson, M ;
Decker, T ;
Roongta, VA ;
Bonilla, L ;
Mayo, KH ;
MacPherson, JC ;
Hazen, SL ;
Slungaard, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (01) :215-224
[6]   Carbamylation of Serum Albumin as a Risk Factor for Mortality in Patients with Kidney Failure [J].
Berg, Anders H. ;
Drechsler, Christiane ;
Wenger, Julia ;
Buccafusca, Roberto ;
Hod, Tammy ;
Kalim, Sahir ;
Ramma, Wenda ;
Parikh, Samir M. ;
Steen, Hanno ;
Friedman, David J. ;
Danziger, John ;
Wanner, Christoph ;
Thadhani, Ravi ;
Karumanchi, S. Ananth .
SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (175)
[7]   Structural models of human apolipoprotein A-I: a critical analysis and review [J].
Brouillette, CG ;
Anantharamaiah, GM ;
Engler, JA ;
Borhani, DW .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2001, 1531 (1-2) :4-46
[8]   Alterations of erythrocyte structure and cellular susceptibility in patients with chronic renal failure: Effect of haemodialysis and oxidative stress [J].
Brzeszczynska, Joanna ;
Luciak, Marek ;
Gwozdzinsk, Krzysztof .
FREE RADICAL RESEARCH, 2008, 42 (01) :40-48
[9]   Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention [J].
Davies, Michael J. .
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2011, 48 (01) :8-19
[10]  
Ghaffari MA, 2010, IRAN J PHARM RES, V9, P67